• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GCN5在转化生长因子-β1诱导的乳腺癌上皮-间质转化中的作用

Function of GCN5 in the TGF-β1-induced epithelial-to-mesenchymal transition in breast cancer.

作者信息

Zhao Liming, Pang Aixia, Li Yunchun

机构信息

Department of Nuclear Medicine, Linyi People's Hospital, Linyi, Shandong 276000, P.R. China.

Department of Urology, Linyi People's Hospital, Linyi, Shandong 276000, P.R. China.

出版信息

Oncol Lett. 2018 Sep;16(3):3955-3963. doi: 10.3892/ol.2018.9134. Epub 2018 Jul 11.

DOI:10.3892/ol.2018.9134
PMID:30128014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6096187/
Abstract

Histone acetyltransferase GCN5 is a critical component of the TGF-β/Smad signaling pathway in breast cancer cells; however, it remains unknown whether it is involved in the development and progression of breast cancer. The present study investigated the role of GCN5 in the induction of the EMT by TGF-β1 in breast cancer cells and its underlying molecular mechanism of action. GCN5 activity was elevated and GCN5 mRNA expression and protein expression were increased in MDA-MB231 cells following stimulation with TGF-β1. Furthermore, TGF-β1 stimulation decreased expression of the epithelial cell marker E-cadherin and increased expression of the mesenchymal cell markers, N-cadherin and vimentin, as well as the expression of other EMT markers, including snail and slug. However, these changes were reversed following GCN5 knockdown leading to the downregulation of GCN5 expression. GCN5 knockdown also inhibited the viability, migration and invasion of MDA-MB231 cells, decreased the expression of p-STAT3, p-AKT, MMP9 and E2F1, and increased the expression of p21 in MDA-MB231 cells compared with cells stimulated with TGF-β1 alone. Therefore, GCN5 may work downstream of TGF-β/Smad signaling pathway to regulate the EMT in breast cancer.

摘要

组蛋白乙酰转移酶GCN5是乳腺癌细胞中TGF-β/Smad信号通路的关键组成部分;然而,其是否参与乳腺癌的发生发展仍不清楚。本研究探讨了GCN5在TGF-β1诱导乳腺癌细胞上皮-间质转化(EMT)中的作用及其潜在的分子作用机制。用TGF-β1刺激MDA-MB231细胞后,GCN5活性升高,GCN5 mRNA表达和蛋白表达增加。此外,TGF-β1刺激降低了上皮细胞标志物E-钙黏蛋白的表达,增加了间充质细胞标志物N-钙黏蛋白和波形蛋白的表达,以及其他EMT标志物(包括蜗牛蛋白和蛞蝓蛋白)的表达。然而,在GCN5基因敲低导致GCN5表达下调后,这些变化发生了逆转。与仅用TGF-β1刺激的细胞相比,GCN5基因敲低还抑制了MDA-MB231细胞的活力、迁移和侵袭,降低了p-STAT3、p-AKT、MMP9和E2F1的表达,并增加了MDA-MB231细胞中p21的表达。因此,GCN5可能在TGF-β/Smad信号通路的下游发挥作用,以调节乳腺癌中的EMT。

相似文献

1
Function of GCN5 in the TGF-β1-induced epithelial-to-mesenchymal transition in breast cancer.GCN5在转化生长因子-β1诱导的乳腺癌上皮-间质转化中的作用
Oncol Lett. 2018 Sep;16(3):3955-3963. doi: 10.3892/ol.2018.9134. Epub 2018 Jul 11.
2
Qinggan Huoxue Recipe suppresses epithelial-to-mesenchymal transition in alcoholic liver fibrosis through TGF-β1/Smad signaling pathway.清肝活血方通过TGF-β1/Smad信号通路抑制酒精性肝纤维化中的上皮-间质转化。
World J Gastroenterol. 2016 May 21;22(19):4695-706. doi: 10.3748/wjg.v22.i19.4695.
3
Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.白藜芦醇通过TGF-β1/Smads信号通路介导的Snail/E-钙黏蛋白表达抑制结直肠癌上皮-间质转化。
BMC Cancer. 2015 Mar 5;15:97. doi: 10.1186/s12885-015-1119-y.
4
TOPK promotes epithelial-mesenchymal transition and invasion of breast cancer cells through upregulation of TBX3 in TGF-β1/Smad signaling.TOPK 通过上调 TGF-β1/Smad 信号通路中的 TBX3 促进乳腺癌细胞的上皮-间充质转化和侵袭。
Biochem Biophys Res Commun. 2020 Jan 29;522(1):270-277. doi: 10.1016/j.bbrc.2019.11.104. Epub 2019 Nov 20.
5
Oridonin prevents epithelial-mesenchymal transition and TGF-β1-induced epithelial-mesenchymal transition by inhibiting TGF-β1/Smad2/3 in osteosarcoma.冬凌草甲素通过抑制 TGF-β1/Smad2/3 防止骨肉瘤发生上皮间质转化和 TGF-β1 诱导的上皮间质转化。
Chem Biol Interact. 2018 Dec 25;296:57-64. doi: 10.1016/j.cbi.2018.09.013. Epub 2018 Sep 19.
6
Cytokeratin 18 is necessary for initiation of TGF-β1-induced epithelial-mesenchymal transition in breast epithelial cells.细胞角蛋白18是启动转化生长因子-β1诱导的乳腺上皮细胞上皮-间质转化所必需的。
Mol Cell Biochem. 2016 Dec;423(1-2):21-28. doi: 10.1007/s11010-016-2818-7. Epub 2016 Oct 13.
7
Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells.转化生长因子-β1和-β2表达升高会加速三阴性乳腺癌细胞的上皮-间质转化。
Cytokine. 2015 Sep;75(1):151-8. doi: 10.1016/j.cyto.2015.05.020. Epub 2015 Jun 15.
8
Involvement of gelsolin in TGF-beta 1 induced epithelial to mesenchymal transition in breast cancer cells.凝溶胶蛋白在转化生长因子-β1诱导的乳腺癌细胞上皮-间质转化中的作用
J Biomed Sci. 2015 Oct 20;22:90. doi: 10.1186/s12929-015-0197-0.
9
Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/Smad2/3 signaling pathway in osteosarcoma.白杨素 A 通过抑制骨肉瘤中 TGF-β1/Smad2/3 信号通路逆转 EMT 和 TGF-β1 诱导的 EMT。
Chem Biol Interact. 2019 Jul 1;307:158-166. doi: 10.1016/j.cbi.2019.05.005. Epub 2019 May 4.
10
JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.JAK/STAT3 信号通路对于 TGF-β诱导的肺癌细胞上皮间质转化是必需的。
Int J Oncol. 2014 May;44(5):1643-51. doi: 10.3892/ijo.2014.2310. Epub 2014 Feb 21.

引用本文的文献

1
New breast cancer marker BF-09 is overexpressed in tumor extracts and secreted in serum.新型乳腺癌标志物BF-09在肿瘤提取物中过表达,并分泌到血清中。
Biochem Biophys Rep. 2025 Jun 20;43:102097. doi: 10.1016/j.bbrep.2025.102097. eCollection 2025 Sep.
2
Histone acetylation modulators in breast cancer.乳腺癌中的组蛋白乙酰化调节剂
Breast Cancer Res. 2025 Mar 31;27(1):49. doi: 10.1186/s13058-025-02006-9.
3
Role of microRNAs in triple‑negative breast cancer and new therapeutic concepts (Review).微小RNA在三阴性乳腺癌中的作用及新治疗理念(综述)
Oncol Lett. 2024 Jul 11;28(3):431. doi: 10.3892/ol.2024.14565. eCollection 2024 Sep.
4
NFIC mediates m6A mRNA methylation to orchestrate transcriptional and post-transcriptional regulation to represses malignant phenotype of non-small cell lung cancer cells.NFIC介导m6A mRNA甲基化,以协调转录和转录后调控,从而抑制非小细胞肺癌细胞的恶性表型。
Cancer Cell Int. 2024 Jun 28;24(1):223. doi: 10.1186/s12935-024-03414-1.
5
Deciphering the Epigenetic Symphony of Cancer: Insights and Epigenetic Therapies Implications.解析癌症的表观遗传交响乐:见解与表观遗传治疗启示。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241250317. doi: 10.1177/15330338241250317.
6
Epigenetic regulation of breast cancer metastasis.乳腺癌转移的表观遗传调控。
Cancer Metastasis Rev. 2024 Jun;43(2):597-619. doi: 10.1007/s10555-023-10146-7. Epub 2023 Oct 19.
7
Emerging Role of Epigenetic Modifiers in Breast Cancer Pathogenesis and Therapeutic Response.表观遗传修饰因子在乳腺癌发病机制和治疗反应中的新作用
Cancers (Basel). 2023 Aug 7;15(15):4005. doi: 10.3390/cancers15154005.
8
Bromodomain (BrD) Family Members as Regulators of Cancer Stemness-A Comprehensive Review.溴结构域家族成员作为癌症干性的调控因子——全面综述。
Int J Mol Sci. 2023 Jan 4;24(2):995. doi: 10.3390/ijms24020995.
9
Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond.乳腺癌中的组蛋白修饰及靶向组蛋白修饰的抗癌药物:基础与拓展
Front Pharmacol. 2022 Sep 15;13:946811. doi: 10.3389/fphar.2022.946811. eCollection 2022.
10
Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer.表观遗传学标志物和表观基因组编辑在乳腺癌早期诊断中的研究进展。
Int J Mol Sci. 2022 Aug 23;23(17):9521. doi: 10.3390/ijms23179521.

本文引用的文献

1
Power of PTEN/AKT: Molecular switch between tumor suppressors and oncogenes.PTEN/AKT的作用:肿瘤抑制因子与癌基因之间的分子开关
Oncol Lett. 2016 Jul;12(1):375-378. doi: 10.3892/ol.2016.4636. Epub 2016 May 26.
2
Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer.山奈酚H6抑制转化生长因子-β诱导的上皮-间质转化,并抑制A549肺癌细胞的迁移和侵袭。
Bioorg Med Chem Lett. 2015 Dec 1;25(23):5508-13. doi: 10.1016/j.bmcl.2015.10.067. Epub 2015 Oct 23.
3
Involvement of gelsolin in TGF-beta 1 induced epithelial to mesenchymal transition in breast cancer cells.凝溶胶蛋白在转化生长因子-β1诱导的乳腺癌细胞上皮-间质转化中的作用
J Biomed Sci. 2015 Oct 20;22:90. doi: 10.1186/s12929-015-0197-0.
4
GCN5 Potentiates Glioma Proliferation and Invasion via STAT3 and AKT Signaling Pathways.GCN5通过STAT3和AKT信号通路增强胶质瘤的增殖和侵袭能力。
Int J Mol Sci. 2015 Sep 10;16(9):21897-910. doi: 10.3390/ijms160921897.
5
Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.早期乳腺癌中多西他赛辅助治疗后与播散性肿瘤细胞 (DTC) 状态相关的临床结果。
J Clin Oncol. 2014 Dec 1;32(34):3848-57. doi: 10.1200/JCO.2014.56.9327. Epub 2014 Nov 3.
6
Cancer statistics, 2014.癌症统计数据,2014 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7.
7
Sorafenib inhibits epithelial-mesenchymal transition through an epigenetic-based mechanism in human lung epithelial cells.索拉非尼通过一种基于表观遗传的机制抑制人肺上皮细胞中的上皮-间充质转化。
PLoS One. 2013 May 31;8(5):e64954. doi: 10.1371/journal.pone.0064954. Print 2013.
8
Lysine acetyltransferase GCN5 potentiates the growth of non-small cell lung cancer via promotion of E2F1, cyclin D1, and cyclin E1 expression.赖氨酸乙酰转移酶 GCN5 通过促进 E2F1、细胞周期蛋白 D1 和细胞周期蛋白 E1 的表达促进非小细胞肺癌的生长。
J Biol Chem. 2013 May 17;288(20):14510-14521. doi: 10.1074/jbc.M113.458737. Epub 2013 Mar 29.
9
Cancer statistics, 2012.癌症统计数据,2012 年。
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
10
Sorafenib inhibits transforming growth factor β1-mediated epithelial-mesenchymal transition and apoptosis in mouse hepatocytes.索拉非尼抑制转化生长因子 β1 介导的小鼠肝细胞上皮-间充质转化和细胞凋亡。
Hepatology. 2011 May;53(5):1708-18. doi: 10.1002/hep.24254.